The debacle leaves it dependent on capable but inferior missiles at a time when other major powers are modernizing their nuclear forces. Russia's new RS-28 Sarmat ICBM appeared to suffer a ...

Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today provided an update on the Company’s key priorities for 2025, including plans to advance TP-04 for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This study suggests that hemodynamically stable patients with inferior wall STEMI have no greater risk of hypotensive episodes following NTG administration than patients with STEMI in other areas ...